000 01235 a2200349 4500
005 20250517170040.0
264 0 _c20180802
008 201808s 0 0 eng d
022 _a1365-2710
024 7 _a10.1111/jcpt.12596
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSim, D W
245 0 0 _aCiprofloxacin-induced immune-mediated thrombocytopenia: No cross-reactivity with gemifloxacin.
_h[electronic resource]
260 _bJournal of clinical pharmacy and therapeutics
_cFeb 2018
300 _a134-136 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAnti-Infective Agents
_xadverse effects
650 0 4 _aCiprofloxacin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFluoroquinolones
_xtherapeutic use
650 0 4 _aGemifloxacin
650 0 4 _aHumans
650 0 4 _aNaphthyridines
_xtherapeutic use
650 0 4 _aPneumonia
_xdrug therapy
650 0 4 _aThrombocytopenia
_xchemically induced
700 1 _aYu, J E
700 1 _aJeong, J
700 1 _aKoh, Y-I
773 0 _tJournal of clinical pharmacy and therapeutics
_gvol. 43
_gno. 1
_gp. 134-136
856 4 0 _uhttps://doi.org/10.1111/jcpt.12596
_zAvailable from publisher's website
999 _c27449467
_d27449467